Examination of the role of mutualism in immune evasion

被引:0
|
作者
Gourmet, Lucie [1 ]
Walker-Samuel, Simon [1 ]
Mallick, Parag [2 ]
机构
[1] UCL, Ctr Computat Med, Div Med, London, England
[2] Stanford Univ, Canary Ctr Canc Early Detect, Palo Alto, CA 94304 USA
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
cancer mutualism; evolution; immune evasion; growth kinetics; modelling; EVOLUTION; CANCER; HETEROGENEITY; COOPERATION;
D O I
10.3389/fonc.2024.1406744
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Though the earliest stages of oncogenesis, post initiation, are not well understood, it is generally appreciated that a successful transition from a collection of dysregulated cells to an aggressive tumour requires complex ecological interactions between cancer cells and their environment. One key component of tumorigenesis is immune evasion. To investigate the interplay amongst the ecological behaviour of mutualism and immune evasion, we used a computational simulation framework. Sensitivity analyses of the growth of a virtual tumour implemented as a 2D-hexagonal lattice model suggests tumour survival depends on the interplay between growth rates, mutualism and immune evasion. In 60% of simulations, cancer clones with low growth rates, but exhibiting mutualism were able to evade the immune system and continue progressing suggesting that tumours with equivalent growth rates and no mutualism are more likely to be eliminated than tumours with mutualism. Tumours with faster growth rates showed a lower dependence upon mutualism for progression. Geostatistical analysis showed decreased spatial heterogeneity over time for polyclonal tumours with a high division rate. Overall, these results suggest that in slow growing tumours, mutualism is critical for early tumorigenesis.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Immune evasion by Staphylococci
    Foster, TJ
    NATURE REVIEWS MICROBIOLOGY, 2005, 3 (12) : 948 - 958
  • [42] Immune evasion by anthrax
    Jenny Buckland
    Nature Reviews Immunology, 2002, 2 : 810 - 810
  • [43] Driving immune evasion
    Sarah Seton-Rogers
    Nature Reviews Cancer, 2018, 18 : 67 - 67
  • [44] Glioma immune evasion
    Zoltan Fehervari
    Nature Immunology, 2017, 18 : 487 - 487
  • [45] SCHISTOSOMIASIS IMMUNE EVASION
    KLOTZ, FW
    ANDERSON, S
    ARIASNEGRETE, S
    KOECH, D
    SHERRY, B
    SHER, A
    BIOLOGICAL BULLETIN, 1980, 159 (02): : 496 - 496
  • [46] Immune evasion by poxviruses
    Nazarian, Steven H.
    McFadden, Grant
    FUTURE VIROLOGY, 2006, 1 (01) : 123 - 132
  • [47] Cytomegalovirus immune evasion
    Powers, C.
    DeFilippis, V.
    Malouli, D.
    Frueh, K.
    HUMAN CYTOMEGALOVIRUS, 2008, 325 : 333 - 359
  • [48] Engineering immune evasion
    John R. Mascola
    Nature, 2006, 441 : 161 - 161
  • [49] Immune evasion by adenoviruses
    Mahr, JA
    Gooding, LR
    IMMUNOLOGICAL REVIEWS, 1999, 168 : 121 - 130
  • [50] Immune evasion by staphylococci
    Timothy J. Foster
    Nature Reviews Microbiology, 2005, 3 : 948 - 958